Exploration of nucleos(t)ide analogs cessation in chronic hepatitis B patients with hepatitis B e antigen loss

BACKGROUND: Nucleos(t)ide analogs (NAs) cessation in chronic hepatitis B (CHB) patients remains a matter of debate in clinical practice. Current guidelines recommend that patients with hepatitis B e antigen (HBeAg) seroconversion discontinue NAs after relatively long-term consolidation therapy. Howe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Gastroenterol
Autors principals: Xue, Yan, Zhang, Meng, Li, Tao, Liu, Feng, Zhang, Li-Xin, Fan, Xiao-Ping, Yang, Bao-Hua, Wang, Lei
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2021
Matèries:
Observational Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8047530/
https://ncbi.nlm.nih.gov/pubmed/33911470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v27.i14.1497
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars